Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cougar Biotechnology, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Advanced Multiple Myeloma.
Progression after ≥ 2 lines of prior therapy, including at least one steroid, one immunomodulatory agent (iMID), one alkylator, and bortezomib (VELCADE®).
ECOG performance status of either 0 or 1.
You may not be if
Prior chemotherapy with antimicrotubule agents
Metastasis involving the brain or spinal cord
Clinically significant lung or heart disease
Abnormal electrocardiogram
Site personnel will explain the trial in detail and answer any question you may have if you do qualify for the study. You can then decide whether or not you wish to participate. If you do not qualify for the trial, site personnel will explain the reasons.
